215 related articles for article (PubMed ID: 30277049)
1. [Not Available].
Hompland I; Hølmebakk T; Boye K; Stoldt S; Bjerkehagen B; Berner JM; Wiedswang AM; Revheim ME; Poulsen JP; Hall KS; Bruland ØS
Tidsskr Nor Laegeforen; 2018 Oct; 138(15):. PubMed ID: 30277049
[TBL] [Abstract][Full Text] [Related]
2. [Gastrointestinal stromal tumors (GIST)].
Jaros D; Bozic B; Sebesta C
Wien Med Wochenschr; 2023 Jun; 173(9-10):201-205. PubMed ID: 36155864
[TBL] [Abstract][Full Text] [Related]
3. Molecular pathology of gastrointestinal stromal tumors and implications for treatment and prognosis.
Parkin B; Chugh R
Curr Probl Cancer; 2011; 35(5):245-54. PubMed ID: 22118564
[No Abstract] [Full Text] [Related]
4. [The importance of mutational status in prognosis and therapy of GIST].
Comandone A; Boglione A
Recenti Prog Med; 2015 Jan; 106(1):17-22. PubMed ID: 25621775
[TBL] [Abstract][Full Text] [Related]
5. A case of multiple gastrointestinal stromal tumors caused by a germline KIT gene mutation (p.Leu576Pro).
Vale Rodrigues R; Santos F; Pereira da Silva J; Francisco I; Claro I; Albuquerque C; Lemos MM; Limbert M; Dias Pereira A
Fam Cancer; 2017 Apr; 16(2):267-270. PubMed ID: 27771813
[TBL] [Abstract][Full Text] [Related]
6. [Gastrointestinal stromal tumour (GIST): current standards in multimodal management].
Reichardt P; Reichardt A
Zentralbl Chir; 2011 Aug; 136(4):359-63. PubMed ID: 21863513
[TBL] [Abstract][Full Text] [Related]
7. Concomitant KIT/BRAF and PDGFRA/BRAF mutations are rare events in gastrointestinal stromal tumors.
Rossi S; Sbaraglia M; Dell'Orto MC; Gasparotto D; Cacciatore M; Boscato E; Carraro V; Toffolatti L; Gallina G; Niero M; Pilozzi E; Mandolesi A; Sessa F; Sonzogni A; Mancini C; Mazzoleni G; Romeo S; Maestro R; Dei Tos AP
Oncotarget; 2016 May; 7(21):30109-18. PubMed ID: 27097112
[TBL] [Abstract][Full Text] [Related]
8. Serum miR-518e-5p is a potential biomarker for secondary imatinib-resistant gastrointestinal stromal tumor.
Kou Y; Yang R; Wang Q
J Biosci; 2018 Dec; 43(5):1015-1023. PubMed ID: 30541960
[TBL] [Abstract][Full Text] [Related]
9. Molecular cytology genotyping of primary and metastatic GI stromal tumors by using a custom two-gene targeted next-generation sequencing panel with therapeutic intent.
Gleeson FC; Kerr SE; Kipp BR; Voss JS; Minot DM; Tu ZJ; Henry MR; Vasmatzis G; Cheville JC; Lazaridis KN; Levy MJ
Gastrointest Endosc; 2016 Dec; 84(6):950-958.e3. PubMed ID: 27118626
[TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal stromal tumour.
Joensuu H; Hohenberger P; Corless CL
Lancet; 2013 Sep; 382(9896):973-83. PubMed ID: 23623056
[TBL] [Abstract][Full Text] [Related]
11. A Case of Disseminated Intra-abdominal Gastrointestinal Stromal Tumor Managed with Low Dose Imatinib.
Jang BH; Kim BW; Lim KJ; Kim BG; Park SM; Kim JS; Ji JS; Choi H
Korean J Gastroenterol; 2015 Jun; 65(6):366-9. PubMed ID: 26087692
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathology and molecular diagnostics of gastrointestinal stromal tumors.
Lucas DR
Curr Probl Cancer; 2011; 35(5):233-44. PubMed ID: 22118563
[No Abstract] [Full Text] [Related]
13. Knowns and Known Unknowns of Gastrointestinal Stromal Tumor Adjuvant Therapy.
Martínez-Marín V; Maki RG
Gastroenterol Clin North Am; 2016 Sep; 45(3):477-86. PubMed ID: 27546844
[TBL] [Abstract][Full Text] [Related]
14. GEIS guidelines for gastrointestinal sarcomas (GIST).
Poveda A; García Del Muro X; López-Guerrero JA; Cubedo R; Martínez V; Romero I; Serrano C; Valverde C; Martín-Broto J;
Cancer Treat Rev; 2017 Apr; 55():107-119. PubMed ID: 28351781
[TBL] [Abstract][Full Text] [Related]
15. [The role of pathologists in the target therapy of gastrointestinal tumors].
Liang ZY
Zhonghua Bing Li Xue Za Zhi; 2010 Jul; 39(7):433-5. PubMed ID: 21055169
[No Abstract] [Full Text] [Related]
16. Classification of KIT/PDGFRA wild-type gastrointestinal stromal tumors: implications for therapy.
Huss S; Elges S; Trautmann M; Sperveslage J; Hartmann W; Wardelmann E
Expert Rev Anticancer Ther; 2015 Jun; 15(6):623-8. PubMed ID: 25831232
[TBL] [Abstract][Full Text] [Related]
17. Gastrointestinal stromal tumors: A multidisciplinary challenge.
Sanchez-Hidalgo JM; Duran-Martinez M; Molero-Payan R; Rufian-Peña S; Arjona-Sanchez A; Casado-Adam A; Cosano-Alvarez A; Briceño-Delgado J
World J Gastroenterol; 2018 May; 24(18):1925-1941. PubMed ID: 29760538
[TBL] [Abstract][Full Text] [Related]
18. Imatinib-Sensitizing KIT Mutation in a Carney-Stratakis-Associated GI Stromal Tumor.
Gasparotto D; Rossi S; Campagna D; Scavina P; Tiziano FD; Marzotto A; Toffolatti L; Vitelli CE; Amini M; Dei Tos AP; Maestro R
J Clin Oncol; 2016 Apr; 34(11):e99-e103. PubMed ID: 25547508
[No Abstract] [Full Text] [Related]
19. [Application and value of mutation detection in diagnosis and treatment of gastrointestinal stromal tumor].
Cao H; Wang M
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Mar; 16(3):208-11. PubMed ID: 23536336
[TBL] [Abstract][Full Text] [Related]
20. Hedgehog pathway dysregulation contributes to the pathogenesis of human gastrointestinal stromal tumors via GLI-mediated activation of KIT expression.
Tang CM; Lee TE; Syed SA; Burgoyne AM; Leonard SY; Gao F; Chan JC; Shi E; Chmielecki J; Morosini D; Wang K; Ross JS; Kendrick ML; Bardsley MR; Siena M; Mao J; Harismendy O; Ordog T; Sicklick JK
Oncotarget; 2016 Nov; 7(48):78226-78241. PubMed ID: 27793025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]